Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G-protein activated inward rectifier potassium channel activity	KCNJ3 KCNJ5 KCNJ6	3.77e-07	4	92	3	GO:0015467
GeneOntologyMolecularFunction	voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization	KCNJ3 KCNJ5	1.25e-04	4	92	2	GO:0086089
GeneOntologyMolecularFunction	inward rectifier potassium channel activity	KCNJ3 KCNJ5 KCNJ6	2.85e-04	28	92	3	GO:0005242
GeneOntologyMolecularFunction	ATP-dependent activity	DHX16 KIF18A ABCA6 MYO6 KIF21A SHOC1 CHD1 ZNFX1 TOP2B DHX30	5.26e-04	614	92	10	GO:0140657
GeneOntologyMolecularFunction	pattern recognition receptor activity	DHX16 TLR2 TLR7	5.57e-04	35	92	3	GO:0038187
GeneOntologyCellularComponent	I(KACh) inward rectifier potassium channel complex	KCNJ3 KCNJ5	2.00e-05	2	94	2	GO:1990566
GeneOntologyCellularComponent	RAVE complex	DMXL2 DMXL1	5.98e-05	3	94	2	GO:0043291
GeneOntologyCellularComponent	inward rectifier potassium channel complex	KCNJ3 KCNJ5	1.19e-04	4	94	2	GO:1902937
GeneOntologyCellularComponent	B-WICH complex	BAZ1B DEK	5.50e-04	8	94	2	GO:0110016
Domain	Rav1p_C	DMXL2 DMXL1	2.35e-05	2	91	2	IPR022033
Domain	TMEM183	TMEM183A TMEM183BP	2.35e-05	2	91	2	IPR026509
Domain	Ribosomal_L44e	RPL36AL RPL36A	2.35e-05	2	91	2	IPR000552
Domain	Ribosomal_L44	RPL36AL RPL36A	2.35e-05	2	91	2	PF00935
Domain	Ribosomal_L44e	RPL36AL RPL36A	2.35e-05	2	91	2	PD002841
Domain	RIBOSOMAL_L44E	RPL36AL RPL36A	2.35e-05	2	91	2	PS01172
Domain	Rav1p_C	DMXL2 DMXL1	2.35e-05	2	91	2	PF12234
Domain	-	RPL36AL RPL36A	2.35e-05	2	91	2	3.10.450.80
Domain	K_chnl_inward-rec_Kir_cyto	KCNJ3 KCNJ5 KCNJ6	5.98e-05	16	91	3	IPR013518
Domain	IRK	KCNJ3 KCNJ5 KCNJ6	5.98e-05	16	91	3	PF01007
Domain	-	KCNJ3 KCNJ5 KCNJ6	5.98e-05	16	91	3	2.60.40.1400
Domain	K_chnl_inward-rec_Kir	KCNJ3 KCNJ5 KCNJ6	5.98e-05	16	91	3	IPR016449
Domain	Laminin_aI	LAMA2 LAMA3	2.33e-04	5	91	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA3	2.33e-04	5	91	2	PF06008
Domain	Laminin_II	LAMA2 LAMA3	2.33e-04	5	91	2	PF06009
Domain	Laminin_domII	LAMA2 LAMA3	2.33e-04	5	91	2	IPR010307
Domain	TRP_dom	TRPC1 TRPC4	3.48e-04	6	91	2	IPR013555
Domain	TRP_2	TRPC1 TRPC4	3.48e-04	6	91	2	PF08344
Domain	TRPC_channel	TRPC1 TRPC4	4.85e-04	7	91	2	IPR002153
Domain	LAMININ_IVA	LAMA2 LAMA3	6.45e-04	8	91	2	PS51115
Domain	Laminin_B	LAMA2 LAMA3	6.45e-04	8	91	2	PF00052
Domain	LamB	LAMA2 LAMA3	6.45e-04	8	91	2	SM00281
Domain	Laminin_IV	LAMA2 LAMA3	6.45e-04	8	91	2	IPR000034
Domain	DNA/RNA_helicase_DEAH_CS	DHX16 CHD1 DHX30	6.54e-04	35	91	3	IPR002464
Domain	Ribosomal_zn-bd	RPL36AL RPL36A	8.27e-04	9	91	2	IPR011332
Domain	DEAH_ATP_HELICASE	DHX16 CHD1 DHX30	8.34e-04	38	91	3	PS00690
Domain	TRP_channel	TRPC1 TRPC4	1.25e-03	11	91	2	IPR004729
Domain	Laminin_N	LAMA2 LAMA3	2.70e-03	16	91	2	IPR008211
Domain	LAMININ_NTER	LAMA2 LAMA3	2.70e-03	16	91	2	PS51117
Domain	Laminin_N	LAMA2 LAMA3	2.70e-03	16	91	2	PF00055
Domain	LamNT	LAMA2 LAMA3	2.70e-03	16	91	2	SM00136
Domain	SMALL_CYTOKINES_CXC	CXCL10 CXCL17	3.04e-03	17	91	2	PS00471
Domain	DUF1605	DHX16 DHX30	3.04e-03	17	91	2	IPR011709
Domain	OB_NTP_bind	DHX16 DHX30	3.04e-03	17	91	2	PF07717
Domain	HA2	DHX16 DHX30	3.41e-03	18	91	2	SM00847
Domain	HA2	DHX16 DHX30	3.41e-03	18	91	2	PF04408
Domain	Helicase-assoc_dom	DHX16 DHX30	3.41e-03	18	91	2	IPR007502
Domain	TIR	TLR2 TLR7	4.64e-03	21	91	2	SM00255
Domain	TIR	TLR2 TLR7	5.09e-03	22	91	2	PF01582
Domain	Znf_C2H2-like	ZNF34 ZNF789 ZBTB25 ZNF652 ZNF804B ZBTB47 ZNF564 ZMAT1 ZFY ZNF292	5.33e-03	796	91	10	IPR015880
Domain	-	TLR2 TLR7	5.56e-03	23	91	2	3.40.50.10140
Domain	Znf_C2H2	ZNF34 ZNF789 ZBTB25 ZNF652 ZNF804B ZBTB47 ZNF564 ZMAT1 ZFY ZNF292	5.76e-03	805	91	10	IPR007087
Domain	ZnF_C2H2	ZNF34 ZNF789 ZBTB25 ZNF652 ZNF804B ZBTB47 ZNF564 ZMAT1 ZFY ZNF292	5.90e-03	808	91	10	SM00355
Domain	TIR	TLR2 TLR7	6.04e-03	24	91	2	PS50104
Domain	TIR_dom	TLR2 TLR7	6.55e-03	25	91	2	IPR000157
Domain	EGF_LAM_2	LAMA2 LAMA3	9.35e-03	30	91	2	PS50027
Domain	EGF_LAM_1	LAMA2 LAMA3	9.35e-03	30	91	2	PS01248
Pubmed	Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.	KCNJ3 KCNJ5 KCNJ6	7.63e-08	4	94	3	15142872
Pubmed	Molecular properties of neuronal G-protein-activated inwardly rectifying K+ channels.	KCNJ3 KCNJ5 KCNJ6	7.63e-08	4	94	3	7499385
Pubmed	Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells.	KCNJ3 KCNJ5 KCNJ6	7.63e-08	4	94	3	8630252
Pubmed	Structural characterization of the mouse Girk genes.	KCNJ3 KCNJ5 KCNJ6	7.63e-08	4	94	3	11891065
Pubmed	Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.	KCNJ3 KCNJ5 KCNJ6	7.63e-08	4	94	3	16109170
Pubmed	Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum.	KCNJ3 KCNJ5 KCNJ6	7.63e-08	4	94	3	18088366
Pubmed	Intracellular trafficking and assembly of specific Kir3 channel/G protein complexes.	KCNJ3 KCNJ5 KCNJ6	1.90e-07	5	94	3	19135528
Pubmed	Subcellular compartment-specific molecular diversity of pre- and post-synaptic GABA-activated GIRK channels in Purkinje cells.	KCNJ3 KCNJ5 KCNJ6	1.90e-07	5	94	3	19558451
Pubmed	Cloning provides evidence for a family of inward rectifier and G-protein coupled K+ channels in the brain.	KCNJ3 KCNJ5 KCNJ6	1.90e-07	5	94	3	7926018
Pubmed	Binding of the G protein betagamma subunit to multiple regions of G protein-gated inward-rectifying K+ channels.	KCNJ3 KCNJ5 KCNJ6	1.90e-07	5	94	3	9108307
Pubmed	RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area.	KCNJ3 KCNJ5 KCNJ6	3.80e-07	6	94	3	17965710
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DHX16 DMXL2 RIOK1 COQ8A ORC3 NEMF ZNFX1 MFSD12 RSBN1L RHOT1 WDR48	1.52e-06	650	94	11	38777146
Pubmed	G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase.	KCNJ3 KCNJ5 KCNJ6	1.59e-06	9	94	3	12297500
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	DHX16 RPL36AL RPL36A BAZ1B CHD1 TOP2B HERC5	5.63e-06	251	94	7	28077445
Pubmed	The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.	MYO6 BAZ1B CHD1 DEK TOP2B HERC5 DHX30	5.93e-06	253	94	7	29911972
Pubmed	Variable Responsiveness to Agonists for TLR2 and TLR7 in Myometrial Cells from Different Sources: Correlation with Receptor Expression.	TLR2 TLR7	7.23e-06	2	94	2	32124394
Pubmed	Identification of native atrial G-protein-regulated inwardly rectifying K+ (GIRK4) channel homomultimers.	KCNJ3 KCNJ5	7.23e-06	2	94	2	9765280
Pubmed	PKCα promotes insulin secretion via TRPC1 phosphorylation in INS-1E cells.	TRPC1 PRKCA	7.23e-06	2	94	2	31094294
Pubmed	TLR2 controls random motility, while TLR7 regulates chemotaxis of microglial cells via distinct pathways.	TLR2 TLR7	7.23e-06	2	94	2	27554518
Pubmed	Identification of critical residues controlling G protein-gated inwardly rectifying K(+) channel activity through interactions with the beta gamma subunits of G proteins.	KCNJ3 KCNJ5	7.23e-06	2	94	2	11741896
Pubmed	BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.	CCNB3 BCOR	7.23e-06	2	94	2	31876361
Pubmed	Cardiac strong inward rectifier potassium channels.	KCNJ3 KCNJ5	7.23e-06	2	94	2	19703462
Pubmed	Mucolipin 1 positively regulates TLR7 responses in dendritic cells by facilitating RNA transportation to lysosomes.	TLR7 MCOLN1	7.23e-06	2	94	2	25239130
Pubmed	Developmental regulation of human embryonic stem cell-derived neurons by calcium entry via transient receptor potential channels.	TRPC1 TRPC4	7.23e-06	2	94	2	19725137
Pubmed	The 2'-O-methylation status of a single guanosine controls transfer RNA-mediated Toll-like receptor 7 activation or inhibition.	TLR2 TLR7	7.23e-06	2	94	2	22312111
Pubmed	Transcriptional expression of voltage-gated Na⁺ and voltage-independent K⁺ channels in the developing rat superficial dorsal horn.	KCNJ3 KCNJ6	7.23e-06	2	94	2	23219908
Pubmed	Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.	KCNJ3 KCNJ6	7.23e-06	2	94	2	15814785
Pubmed	Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain.	KCNJ3 KCNJ6	7.23e-06	2	94	2	8929423
Pubmed	TRPC4 forms store-operated Ca2+ channels in mouse mesangial cells.	TRPC1 TRPC4	7.23e-06	2	94	2	15044151
Pubmed	G-protein-coupled inward rectifier potassium current contributes to ventricular repolarization.	KCNJ3 KCNJ5	7.23e-06	2	94	2	24148898
Pubmed	A recombinant inwardly rectifying potassium channel coupled to GTP-binding proteins.	KCNJ3 KCNJ5	7.23e-06	2	94	2	8868049
Pubmed	A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion.	CCNB3 BCOR	7.23e-06	2	94	2	22387997
Pubmed	The effect of Toll-like receptor stimulation on the motility of regulatory T cells.	TLR2 TLR7	7.23e-06	2	94	2	33189487
Pubmed	Differential subunit composition of the G protein-activated inward-rectifier potassium channel during cardiac development.	KCNJ3 KCNJ5	7.23e-06	2	94	2	15467839
Pubmed	Toll-like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis.	TLR2 TLR7	7.23e-06	2	94	2	31211901
Pubmed	Macromolecular organization of basement membranes.	LAMA2 LAMA3	7.23e-06	2	94	2	8939648
Pubmed	TRPC channels determine human keratinocyte differentiation: new insight into basal cell carcinoma.	TRPC1 TRPC4	7.23e-06	2	94	2	17920677
Pubmed	Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup.	TMEM183A TMEM183BP	7.23e-06	2	94	2	16644869
Pubmed	BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.	CCNB3 BCOR	7.23e-06	2	94	2	24805859
Pubmed	The GIRK1 subunit potentiates G protein activation of cardiac GIRK1/4 hetero-tetramers.	KCNJ3 KCNJ5	7.23e-06	2	94	2	27074664
Pubmed	Mutant KCNJ3 and KCNJ5 Potassium Channels as Novel Molecular Targets in Bradyarrhythmias and Atrial Fibrillation.	KCNJ3 KCNJ5	7.23e-06	2	94	2	30764634
Pubmed	TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection.	TLR2 TLR7	7.23e-06	2	94	2	35178710
Pubmed	GIRK4 confers appropriate processing and cell surface localization to G-protein-gated potassium channels.	KCNJ3 KCNJ5	7.23e-06	2	94	2	9891030
Pubmed	An undifferentiated sarcoma with BCOR-CCNB3 fusion transcript - pathological and clinical retrospective study.	CCNB3 BCOR	7.23e-06	2	94	2	30064235
Pubmed	Heteromeric canonical transient receptor potential 1 and 4 channels play a critical role in epileptiform burst firing and seizure-induced neurodegeneration.	TRPC1 TRPC4	7.23e-06	2	94	2	22144671
Pubmed	Genetic variation in the inwardly rectifying K channel subunits KCNJ3 (GIRK1) and KCNJ5 (GIRK4) in patients with sinus node dysfunction.	KCNJ3 KCNJ5	7.23e-06	2	94	2	20110696
Pubmed	Suppression of inhibitory G protein signaling in forebrain pyramidal neurons triggers plasticity of glutamatergic neurotransmission in the nucleus accumbens core.	KCNJ3 KCNJ6	7.23e-06	2	94	2	28131769
Pubmed	Gi/o-coupled muscarinic receptors co-localize with GIRK channel for efficient channel activation.	KCNJ3 KCNJ6	7.23e-06	2	94	2	30240440
Pubmed	Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh.	KCNJ3 KCNJ5	7.23e-06	2	94	2	12374786
Pubmed	Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2.	KCNJ3 KCNJ6	7.23e-06	2	94	2	9023358
Pubmed	Crucial role of TRPC1 and TRPC4 in cystitis-induced neuronal sprouting and bladder overactivity.	TRPC1 TRPC4	7.23e-06	2	94	2	23922735
Pubmed	Distinct populations of spinal cord lamina II interneurons expressing G-protein-gated potassium channels.	KCNJ3 KCNJ6	7.23e-06	2	94	2	17122050
Pubmed	During post-natal human myogenesis, normal myotube size requires TRPC1- and TRPC4-mediated Ca²⁺ entry.	TRPC1 TRPC4	7.23e-06	2	94	2	23549783
Pubmed	Keratinocyte TLR2 and TLR7 contribute to chronic itch through pruritic cytokines and chemokines in mice.	TLR2 TLR7	7.23e-06	2	94	2	36436135
Pubmed	Clinicopathologic Diversity of Undifferentiated Sarcoma With BCOR-CCNB3 Fusion: Analysis of 11 Cases With a Reappraisal of the Utility of Immunohistochemistry for BCOR and CCNB3.	CCNB3 BCOR	7.23e-06	2	94	2	28877060
Pubmed	Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues.	CCNB3 BCOR	7.23e-06	2	94	2	28817404
Pubmed	Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.	TLR2 TLR7	7.23e-06	2	94	2	28432147
Pubmed	Identification of a Kir3.4 mutation in congenital long QT syndrome.	KCNJ3 KCNJ5	7.23e-06	2	94	2	20560207
Pubmed	Conformational dynamics of Kir3.1/Kir3.2 channel activation via δ-opioid receptors.	KCNJ3 KCNJ6	7.23e-06	2	94	2	23175530
Pubmed	BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.	CCNB3 BCOR	7.23e-06	2	94	2	25360585
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	LENG8 RIOK1 RPL36A MYO6 BAZ1B CHD1 BCOR DCTN1 RSBN1L TOP2B HERC5 DHX30	8.31e-06	934	94	12	33916271
Pubmed	International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels.	KCNJ3 KCNJ5 KCNJ6	8.50e-06	15	94	3	16382105
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYT1L ZNF34 DMXL2 OXR1 MYO6 KCNJ6 KIF21A NEMF ZBTB47 ZNFX1 DCTN1 RSBN1L DHX30 ZNF292	9.09e-06	1285	94	14	35914814
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	CHD1 BCOR DEK ZFY DHX30	1.21e-05	109	94	5	33554859
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	DHX16 PRPSAP2 MYO6 RAB3GAP2 BAZ1B VTA1 DCTN1 TOP2B RHOT1 DHX30	2.12e-05	704	94	10	29955894
Pubmed	Heteromeric channels formed by TRPC1, TRPC4 and TRPC5 define hippocampal synaptic transmission and working memory.	TRPC1 TRPC4	2.16e-05	3	94	2	28790178
Pubmed	Suggestive evidence for association of two potassium channel genes with different idiopathic generalised epilepsy syndromes.	KCNJ3 KCNJ6	2.16e-05	3	94	2	12458027
Pubmed	Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels.	TRPC1 TRPC4	2.16e-05	3	94	2	30755645
Pubmed	Interaction between TRPC1/TRPC4 assembly and STIM1 contributes to store-operated Ca2+ entry in mesangial cells.	TRPC1 TRPC4	2.16e-05	3	94	2	19307462
Pubmed	Atrial GIRK Channels Mediate the Effects of Vagus Nerve Stimulation on Heart Rate Dynamics and Arrhythmogenesis.	KCNJ3 KCNJ5	2.16e-05	3	94	2	30072916
Pubmed	FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.	FGFR2 FGF18	2.16e-05	3	94	2	32934314
Pubmed	The Ca(2+) sensor stromal interaction molecule 1 (STIM1) is necessary and sufficient for the store-operated Ca(2+) entry function of transient receptor potential canonical (TRPC) 1 and 4 channels in endothelial cells.	TRPC1 TRPC4	2.16e-05	3	94	2	22210847
Pubmed	Expression of transient receptor channel proteins in human fundal myometrium in pregnancy.	TRPC1 TRPC4	2.16e-05	3	94	2	16527499
Pubmed	TLR2 Activation Limits Rhinovirus-Stimulated CXCL-10 by Attenuating IRAK-1-Dependent IL-33 Receptor Signaling in Human Bronchial Epithelial Cells.	CXCL10 TLR2	2.16e-05	3	94	2	27503209
Pubmed	Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice.	KCNJ5 KCNJ6	2.16e-05	3	94	2	12499858
Pubmed	Runx1 is involved in the fusion of the primary and the secondary palatal shelves.	FGFR2 FGF18	2.16e-05	3	94	2	19000669
Pubmed	Molecular cloning of a mouse G-protein-activated K+ channel (mGIRK1) and distinct distributions of three GIRK (GIRK1, 2 and 3) mRNAs in mouse brain.	KCNJ3 KCNJ6	2.16e-05	3	94	2	7702616
Pubmed	Identification of GIRK2-4 subunits in human esophageal smooth muscle cells.	KCNJ5 KCNJ6	2.16e-05	3	94	2	21637918
Pubmed	Characterisation of an mRNA encoding a human ribosomal protein homologous to the yeast L44 ribosomal protein.	RPL36AL RPL36A	2.16e-05	3	94	2	3542712
Pubmed	Regulation of TRPC1 and TRPC4 cation channels requires an alpha1-syntrophin-dependent complex in skeletal mouse myotubes.	TRPC1 TRPC4	2.16e-05	3	94	2	19812031
Pubmed	Developmental regulation of G protein-gated inwardly-rectifying K+ (GIRK/Kir3) channel subunits in the brain.	KCNJ3 KCNJ6	2.16e-05	3	94	2	22098295
Pubmed	Role of FGFR2b expression and signaling in keratinocyte differentiation: sequential involvement of PKCδ and PKCα.	PRKCA FGFR2	2.16e-05	3	94	2	29752438
Pubmed	Transient Receptor Potential C 1/4/5 Is a Determinant of MTI-101 Induced Calcium Influx and Cell Death in Multiple Myeloma.	TRPC1 TRPC4	2.16e-05	3	94	2	34199280
Pubmed	Behavioral characterization of mice lacking GIRK/Kir3 channel subunits.	KCNJ3 KCNJ6	2.16e-05	3	94	2	18194467
Pubmed	Developmental expression of the GIRK family of inward rectifying potassium channels: implications for abnormalities in the weaver mutant mouse.	KCNJ3 KCNJ6	2.16e-05	3	94	2	9459542
Pubmed	A glutamate residue at the C terminus regulates activity of inward rectifier K+ channels: implication for Andersen's syndrome.	KCNJ3 KCNJ6	2.16e-05	3	94	2	12034888
Pubmed	TRPC1 and TRPC4 channels functionally interact with STIM1L to promote myogenesis and maintain fast repetitive Ca2+ release in human myotubes.	TRPC1 TRPC4	2.16e-05	3	94	2	28185894
Pubmed	A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).	CCNB3 BCOR	2.16e-05	3	94	2	36791667
Pubmed	Molecular and cellular diversity of neuronal G-protein-gated potassium channels.	KCNJ3 KCNJ6	2.16e-05	3	94	2	16339040
Pubmed	Altered neurotransmission in the mesolimbic reward system of Girk mice.	KCNJ3 KCNJ6	2.16e-05	3	94	2	20557431
Pubmed	Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia.	KCNJ3 KCNJ6	2.16e-05	3	94	2	15028774
Pubmed	TRPC1/4/5 channels contribute to morphine-induced analgesic tolerance and hyperalgesia by enhancing spinal synaptic potentiation and structural plasticity.	TRPC1 TRPC4	2.16e-05	3	94	2	32359120
Pubmed	Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.	CXCL10 TLR2	2.16e-05	3	94	2	19447045
Pubmed	TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors.	TLR2 TLR7	2.16e-05	3	94	2	20821041
Pubmed	Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease.	TLR2 TLR7	2.16e-05	3	94	2	31048358
Pubmed	Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels.	TRPC1 TRPC4	2.16e-05	3	94	2	28325835
Pubmed	Analysis of Mrgprb2 Receptor-Evoked Ca 2+ Signaling in Bone Marrow Derived (BMMC) and Peritoneal (PMC) Mast Cells of TRPC-Deficient Mice.	TRPC1 TRPC4	2.16e-05	3	94	2	32322252
Pubmed	In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C.	TLR2 TLR7	2.16e-05	3	94	2	23489702
Pubmed	CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan.	CXCL10 TLR2	2.16e-05	3	94	2	22491449
Pubmed	HL-1 cells express an inwardly rectifying K+ current activated via muscarinic receptors comparable to that in mouse atrial myocytes.	KCNJ3 KCNJ5	2.16e-05	3	94	2	20186548
GeneFamily	Potassium voltage-gated channel subfamily J	KCNJ3 KCNJ5 KCNJ6	2.29e-05	16	64	3	276
GeneFamily	Transient receptor potential cation channels	TRPC1 TRPC4 MCOLN1	1.30e-04	28	64	3	249
GeneFamily	CD molecules\|Toll like receptors	TLR2 TLR7	5.45e-04	10	64	2	948
GeneFamily	Laminin subunits	LAMA2 LAMA3	7.96e-04	12	64	2	626
GeneFamily	DEAH-box helicases	DHX16 DHX30	1.43e-03	16	64	2	500
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF34 ZNF789 ZBTB25 ZNF652 ZBTB47 ZNF564 ZFY ZNF292	3.70e-03	718	64	8	28
GeneFamily	Chemokine ligands\|Endogenous ligands	CXCL10 CXCL17	1.11e-02	45	64	2	483
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF18A KIF21A	1.15e-02	46	64	2	622
GeneFamily	WD repeat domain containing	DMXL2 KIF21A DMXL1 WDR48	1.39e-02	262	64	4	362
GeneFamily	L ribosomal proteins	RPL36AL RPL36A	1.41e-02	51	64	2	729
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	MASP1 CR1	1.74e-02	57	64	2	1179
GeneFamily	LIM domain containing	XIRP2 FHL5	1.85e-02	59	64	2	1218
GeneFamily	Proteases, serine	MASP1 TMPRSS6	2.10e-02	63	64	2	738
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	KIF18A MASP1 MYO6 NEMF BAZ1B CHD1 DEK DNAJC2 DMXL1 ZNF292	3.26e-05	469	91	10	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	MYT1L EFHC2 DMXL2 COQ8A CCNB3 ZMAT1 DMXL1	5.97e-05	230	91	7	gudmap_developingGonad_e18.5_ovary_1000_k5
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	OXR1 ST3GAL5 XIRP2 KCNJ5 TLR2 SHOC1 AUTS2	1.07e-07	179	94	7	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A AUTS2 LAMA3 PRKCA FGFR2	1.39e-07	186	94	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A AUTS2 LAMA3 PRKCA FGFR2	1.50e-07	188	94	7	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A AUTS2 LAMA3 FGFR2	2.22e-06	179	94	6	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 ACAD10 FGFR2	2.60e-06	184	94	6	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ST3GAL5 CXCL10 ZNFX1 TLR7 DEK HERC5	3.43e-06	193	94	6	22455801194bd8c73c5c397f5eac4f723429c383
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MASP1 NKD1 KCNJ6 TRPC4 LAMA2 FHL5	3.53e-06	194	94	6	8f19e553f18c313c2a2ff9453884b9484b255d71
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MASP1 NKD1 KCNJ6 TRPC4 LAMA2 FHL5	3.53e-06	194	94	6	67fbb81b7d20cb63be27b2a2beea5b5689f8e08c
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RPL36A MYO6 NEMF DNAJC2 DHX30 ZNF292	3.86e-06	197	94	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	9.30e-06	133	94	5	5bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCell	Control-Epithelial_alveolar-AT_1-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	XIRP2 LAMA3 FGFR2 FHL5 MSMB	1.28e-05	142	94	5	94e277f038f4006d99ff50222b0f5cf89bc3d46d
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	1.83e-05	153	94	5	e7a074ea8232bacf924be78a244a8507c7e1ebc8
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM183A CXCL10 TRPC1 PRKCA ACAD10	3.21e-05	172	94	5	10a1d1838492b8ce6dea08844353b51571432c56
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM183A CXCL10 TRPC1 PRKCA ACAD10	3.21e-05	172	94	5	d824e46c8040b0bb9235f9b8a2b35386b303caa0
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CXCL10 TLR2 VTA1 CR1 RHOT1	3.39e-05	174	94	5	eaaf17a06efc09ed4752b449827b1f0f424d3dad
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	3.39e-05	174	94	5	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MASP1 NKD1 KCNJ6 TRPC4 FHL5	3.89e-05	179	94	5	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.10e-05	181	94	5	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MASP1 NKD1 KCNJ6 TRPC4 FHL5	4.10e-05	181	94	5	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.20e-05	182	94	5	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	Control-Epithelial_alveolar-AT_2-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.20e-05	182	94	5	e97681a4102f3095d5d9e90ad70f1dc46e90983a
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.20e-05	182	94	5	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CXCL10 ZNFX1 TLR7 HERC5 DMXL1	4.32e-05	183	94	5	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.32e-05	183	94	5	06ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.32e-05	183	94	5	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.32e-05	183	94	5	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.43e-05	184	94	5	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.43e-05	184	94	5	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.54e-05	185	94	5	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.54e-05	185	94	5	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.54e-05	185	94	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 LAMA3 ACAD10 FGFR2	4.54e-05	185	94	5	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.54e-05	185	94	5	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 KIF21A LAMA3 ACAD10 FGFR2	4.54e-05	185	94	5	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.54e-05	185	94	5	929b68b05b7686341329ac756d7df172cb4b810b
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.66e-05	186	94	5	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.78e-05	187	94	5	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	NKD1 ABCA6 TRPC4 LAMA2 ELMO1	4.78e-05	187	94	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.78e-05	187	94	5	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MASP1 KCNJ6 TRPC4 LAMA2 FHL5	4.78e-05	187	94	5	8ee3bf885897efd634c3a0567637142a9f55e693
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.91e-05	188	94	5	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	4.91e-05	188	94	5	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MASP1 NKD1 TRPC4 LAMA2 FHL5	4.91e-05	188	94	5	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST3GAL5 CXCL17 KIF21A LAMA3 FGFR2	5.03e-05	189	94	5	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	droplet-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL36A CXCL10 TMPRSS6 TLR2 DEK	5.03e-05	189	94	5	258ef4a52f90236dbed92f325ca033c8fa6156a5
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RPL36AL RBIS ZMAT1 HERC5 ZNF292	5.03e-05	189	94	5	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KCNJ5 TLR2 CR1 ELMO1 CYTH4	5.16e-05	190	94	5	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TLR2 TLR7 CR1 ELMO1 CYTH4	5.16e-05	190	94	5	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 TRPC4 LAMA2 AUTS2 FHL5	5.16e-05	190	94	5	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ST3GAL5 TLR2 AUTS2 LAMA3 FGFR2	5.29e-05	191	94	5	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TLR2 TLR7 CR1 ELMO1 CYTH4	5.29e-05	191	94	5	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.29e-05	191	94	5	47a2afc4102199b4bc76bd01b2967c8016186462
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TLR2 TLR7 CR1 ELMO1 CYTH4	5.42e-05	192	94	5	86d792682ba51696f503c79625dd20f87bcf651f
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.42e-05	192	94	5	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 ABCA6 TRPC4 LAMA2 AUTS2	5.42e-05	192	94	5	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TLR2 TLR7 CR1 ELMO1 CYTH4	5.42e-05	192	94	5	d0ad6a205ad50a3c523fa68676996b289eabc5de
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ST3GAL5 MYO6 TLR2 LAMA3 FGFR2	5.42e-05	192	94	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.56e-05	193	94	5	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.56e-05	193	94	5	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	Posterior_cortex-Neuronal\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MYT1L KCNJ3 KCNJ6 KIF21A AMER3	5.56e-05	193	94	5	b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TLR2 TLR7 CR1 ELMO1 CYTH4	5.56e-05	193	94	5	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.56e-05	193	94	5	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.69e-05	194	94	5	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCNJ5 TLR2 CR1 ELMO1 CYTH4	5.69e-05	194	94	5	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KCNJ5 TLR2 MCOLN1 ELMO1 CYTH4	5.69e-05	194	94	5	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMXL2 CHD1 CR1 MCOLN1 CYTH4	5.69e-05	194	94	5	dfe0ece81922bfd7c6673726d3ea2365cbdb5513
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.69e-05	194	94	5	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 ABCA6 TRPC4 LAMA2 PRKCA	5.83e-05	195	94	5	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	DMXL2 TLR2 CR1 ELMO1 CYTH4	5.83e-05	195	94	5	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	CXCL10 ZNFX1 TLR7 HERC5 DMXL1	5.83e-05	195	94	5	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TLR2 TLR7 CR1 ELMO1 CYTH4	5.83e-05	195	94	5	09df40ff9b493170861b3f6e57a942a834655b5c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCNJ5 TLR2 CR1 ELMO1 CYTH4	5.83e-05	195	94	5	34a9462f4e843f3065cc58c17ad71c1b5b836ae1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 ABCA6 TRPC4 LAMA2 PRKCA	5.98e-05	196	94	5	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TLR2 TLR7 CR1 ELMO1 CYTH4	5.98e-05	196	94	5	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 ABCA6 TRPC4 LAMA2 PRKCA	5.98e-05	196	94	5	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DMXL2 TLR2 CR1 MCOLN1 CYTH4	5.98e-05	196	94	5	1b7928f4eee94d4bb6ea410bab68a471dba12979
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DMXL2 TLR2 CR1 MCOLN1 CYTH4	5.98e-05	196	94	5	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TLR2 CHD1 CR1 CYTH4 CKLF	6.12e-05	197	94	5	340ce4fef244176fb52e38ffbcbdfda5ac3467dd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 ABCA6 TRPC4 LAMA2 PRKCA	6.12e-05	197	94	5	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	Control_saline-Epithelial_alveolar-AT_2\|Control_saline / Treatment groups by lineage, cell group, cell type	ST3GAL5 KIF21A LAMA3 ACAD10 FGFR2	6.12e-05	197	94	5	b8f62fcd6eb8f47b3cc41f616126f82c68a36e87
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NKD1 ABCA6 TRPC4 LAMA2 PRKCA	6.12e-05	197	94	5	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|Control_saline / Treatment groups by lineage, cell group, cell type	ST3GAL5 KIF21A LAMA3 ACAD10 FGFR2	6.27e-05	198	94	5	030ef63e2fc5b3d601c1a48462d797aa19ee7ff5
ToppCell	LPS_anti-TNF-Epithelial_alveolar\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ST3GAL5 KIF21A LAMA3 ACAD10 FGFR2	6.27e-05	198	94	5	53e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ST3GAL5 KIF21A LAMA3 ACAD10 FGFR2	6.27e-05	198	94	5	f006d68e6c51923be7772eea118546a5762e8a5e
ToppCell	COVID-19-kidney-Macrophages\|kidney / Disease (COVID-19 only), tissue and cell type	DMXL2 CXCL10 TLR2 ELMO1 CYTH4	6.27e-05	198	94	5	161324541fe5da5cbb58142ea94fefd39b7dfb04
ToppCell	BAL-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	CXCL10 TLR7 DEK HERC5 CKLF	6.42e-05	199	94	5	9f5750212b887f92761ade33fc6e108cd5275297
ToppCell	LPS_IL1RA-Epithelial_alveolar\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ST3GAL5 KIF21A LAMA3 ACAD10 FGFR2	6.42e-05	199	94	5	5b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNJ5 TLR2 CR1 MCOLN1 CYTH4	6.42e-05	199	94	5	9545ac59c8d75f5747dff86cb511a149dc103b31
ToppCell	Bronchus_Control_(B.)-Immune-TX-MoAM-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ABCA6 KCNJ5 TLR7 CR1 CYTH4	6.42e-05	199	94	5	fb63885273d906a85fef178d859d20a311eb8a72
ToppCell	cellseq2-Immune-Immune_Myeloid-IM-IM\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DMXL2 TLR2 TLR7 CR1 CYTH4	6.42e-05	199	94	5	372fb9eb90022dc4ac770a75b4e207c33d1d0c43
ToppCell	cellseq2-Immune-Immune_Myeloid-IM\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DMXL2 TLR2 TLR7 CR1 CYTH4	6.42e-05	199	94	5	dd3bf59cdc18091889cbf6c43f37100ba537843d
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DMXL2 CXCL10 TLR2 ZNFX1 HERC5	6.42e-05	199	94	5	841338719d042247966867ac608146395eb8c4d9
ToppCell	cellseq2-Immune-Immune_Myeloid\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DMXL2 TLR2 TLR7 CR1 CYTH4	6.42e-05	199	94	5	6c3c9eceea20121ae17ae2462134aa0437f591b3
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ST3GAL5 KIF21A LAMA3 ACAD10 FGFR2	6.58e-05	200	94	5	c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MASP1 NKD1 KCNJ6 TRPC4 FHL5	6.58e-05	200	94	5	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NKD1 ABCA6 TRPC4 LAMA2 ELMO1	6.58e-05	200	94	5	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	distal-mesenchymal-Pericyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MASP1 KCNJ6 TRPC4 LAMA2 FHL5	6.58e-05	200	94	5	867935701fac71a3fe01578362da0676f959736c
ToppCell	mild-CD163+_Monocytes_(Sample_ID1_d7)\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMXL2 CXCL10 TLR2 TLR7 HERC5	6.58e-05	200	94	5	99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5
ToppCell	mild-CD163+_Monocytes_(Sample_ID1_d7)\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMXL2 CXCL10 TLR2 TLR7 HERC5	6.58e-05	200	94	5	82126e25bfd8fba78dc1348fa5ad6a576289a139
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NKD1 ABCA6 TRPC4 LAMA2 ELMO1	6.58e-05	200	94	5	311fab076f2ceb258e3970eb21e39344b894042a
Drug	Mianserin	KCNJ3 KCNJ5 KCNJ6 PRKCA	2.18e-06	23	93	4	ctd:D008803
Drug	Duloxetine Hydrochloride	KCNJ3 KCNJ5 KCNJ6	3.64e-06	8	93	3	ctd:D000068736
Drug	Amoxapine	KCNJ3 KCNJ5 KCNJ6	5.44e-06	9	93	3	ctd:D000657
Drug	A13108	KCNJ3 KCNJ5 KCNJ6	7.75e-06	10	93	3	CID000062278
Drug	AC1Q5QXZ	KCNJ3 KCNJ5 KCNJ6	7.75e-06	10	93	3	CID000031328
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ZNF34 DMXL2 COQ8A ST3GAL5 TRPC1 TRPC4 MSMB	1.10e-05	185	93	7	1022_UP
Drug	Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A	DMXL2 ZNF652 TRPC1 PRKCA FGFR2 CR1 FGF18	1.44e-05	193	93	7	2275_UP
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	COQ8A ST3GAL5 ZBTB25 BAZ1B FGFR2 RHOT1 WDR48	1.60e-05	196	93	7	6970_DN
Drug	Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A	KCNJ3 BAZ1B FGFR2 ZFPL1 HERC5 MSMB WDR48	1.70e-05	198	93	7	5681_DN
Drug	bifeprunox	KCNJ3 KCNJ5 KCNJ6	1.83e-05	13	93	3	CID000208951
Drug	beta-FNA	KCNJ3 KCNJ5 KCNJ6 CYTH4	1.92e-05	39	93	4	CID005137129
Drug	methyl (E)-4-[[(4R,4aR,7R,7aR,12bS)-3-(cyclopropylmethyl)-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]amino]-4-oxobut-2-enoate	KCNJ3 KCNJ5 KCNJ6 CYTH4	2.85e-05	43	93	4	CID016072169
Drug	barium	KCNJ3 KCNJ5 KCNJ6 TRPC1 TRPC4 PRKCA	3.26e-05	148	93	6	CID000104810
Drug	beta-apocarotenoid-14',13'-dioxygenase	KCNJ3 KCNJ6	4.94e-05	3	93	2	ctd:C110027
Drug	NIP142	KCNJ3 KCNJ5	4.94e-05	3	93	2	ctd:C427584
Disease	prostate cancer (implicated_via_orthology)	CHD1 FGFR2 MSMB	1.14e-04	33	84	3	DOID:10283 (implicated_via_orthology)
Disease	Spastic Paraplegia	RAB3GAP2 WDR48	2.85e-04	9	84	2	C0037772
Disease	nicotine dependence (implicated_via_orthology)	TRPC1 TRPC4	5.19e-04	12	84	2	DOID:0050742 (implicated_via_orthology)
Disease	motor neuron disease (implicated_via_orthology)	DCTN1 RHOT1	5.19e-04	12	84	2	DOID:231 (implicated_via_orthology)
Disease	stomach carcinoma (is_implicated_in)	FGFR2 BCOR	5.19e-04	12	84	2	DOID:5517 (is_implicated_in)
Disease	isoleucine measurement	ZNF804B LAMA2 VTA1	5.53e-04	56	84	3	EFO_0009793
Disease	phoneme awareness	KCNJ6 ZNFX1	7.13e-04	14	84	2	EFO_0021812
Disease	protein C measurement	BAZ1B ELMO1	1.06e-03	17	84	2	EFO_0004633
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR2 TLR7	1.06e-03	17	84	2	DOID:8677 (biomarker_via_orthology)
Disease	smoking status measurement	MYT1L ZNF789 KCNJ3 KCNJ6 RAB3GAP2 TRPC4 ZNF804B LAMA2 AUTS2 ELMO1	1.68e-03	1160	84	10	EFO_0006527
Disease	Periodontal Pocket	RIOK1 ELMO1	2.30e-03	25	84	2	EFO_1001393
Disease	complement factor D measurement	MASP1 CXCL10 ELMO1	2.40e-03	93	84	3	EFO_0020283
Disease	Neurodevelopmental Disorders	MYT1L DHX30 ZNF292	2.40e-03	93	84	3	C1535926
Disease	anogenital venereal wart (is_marker_for)	TLR2 TLR7	2.49e-03	26	84	2	DOID:11168 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
FKPVRKCKTHDSMSG	AMER3	86	Q8N944
GTERYQKLQKIMKPC	ELMO1	136	Q92556
QFCKKIRRRMPGTDA	DCTN1	796	Q14203
GFMAPKQKRRKLQSE	BAZ1B	1111	Q9UIG0
CGKKRMRKDPVFRIS	ABCA6	1221	Q8N139
MKARVKSRLAFGKPL	ACAD10	936	Q6JQN1
RKTSKYMPRGSVCNV	DMXL2	241	Q8TDJ6
CIGRKKFNMDPAKGI	CYTH4	66	Q9UIA0
YTNKGMKIACTQPRR	DHX16	441	O60231
CPMTFVAKGRRKAEA	DHX30	286	Q7L2E3
KKLKMSSRIFRCNFP	BCOR	1671	Q6W2J9
RLLFAKMNGCPSRKY	BBOF1	451	Q8ND07
KKNCKAMFPNRRIVT	CC2D2B	1091	Q6DHV5
QKTFSICKERMRPVK	CHD1	1411	O14646
AEAVPGRTKKDCMKR	DNAJC2	581	Q99543
GEKQNKRFRPSKMSC	DMXL1	2386	Q9Y485
KEQCMTEGKRSRLKP	CCNB3	386	Q8WWL7
MGKLHSKPAAVCKRR	NKD1	1	Q969G9
GKKPRQRYMEKSGKC	KCNJ5	46	P48544
FRAKGRKPCKLMLQV	MCOLN1	56	Q9GZU1
KLGFKRAMKCKSIPF	ANKAR	486	Q7Z5J8
RAMKCKSIPFGMKSA	ANKAR	491	Q7Z5J8
YLMDKVGKSPKDRLC	RAB3GAP2	1071	Q9H2M9
ILCRMKNTTKKPDFS	FGFR2	396	P21802
MPRGHKSKLRTCEKR	MAGEB6	1	Q8N7X4
TPAFRGCMKNLKKTS	LAMA3	2731	Q16787
PSSFAMKCRKHLKSR	NEMF	71	O60524
VGCMFVKISQPKKRA	KCNJ6	186	P48051
NICKINPSMVRKFGR	KIF18A	876	Q8NI77
APTKRSRKKMAALEC	LENG8	486	Q96PV6
IAGGMFLKRSRVKKP	EFHC2	476	Q5JST6
MKPACIKALTRIFKI	RHOT1	181	Q8IXI2
FYLCMNRKGKLVGKP	FGF18	106	O76093
RNLCQHLGKRKKMPK	AUTS2	156	Q8WXX7
NKCSGASQKLPRKMV	ISG20L2	166	Q9H9L3
MKARPEVNLKKYSGC	LAMA2	2481	P24043
RKCMDLKGNKHPINS	MSMB	36	P08118
MVNVPKTRRTFCKKC	RPL36AL	1	Q969Q0
RTPKCIKLGKNMKIH	HERC5	86	Q9UII4
EGIKMTPRRQKKLFC	P4HA1	296	P13674
HKFLCLRVGKPMRKT	OXR1	556	Q8N573
KCFHCKRTIMPGSRK	FHL5	101	Q5TD97
VMKGPRRVKCQALNK	CR1	271	P17927
VMKGPRRVKCQALNK	CR1	721	P17927
VMKGPRRVKCQALNK	CR1	1171	P17927
SGMARKAKRTKCPEI	DEK	211	P35659
FCPRVEIIATMKKKG	CXCL10	56	P02778
RKMGGSFLICSKLKA	COQ8A	611	Q8NI60
CGLPKFSRKLMARIF	MASP1	436	P48740
FPYSKQCKMRKRGSI	PRPSAP2	111	O60256
RRKFMTVSGLPKKQC	CXCL17	61	Q6UXB2
GRRKCKPQMNYDKLS	ETV3L	81	Q6ZN32
LSSFLMKPINKCIGR	MFSD12	326	Q6NUT3
MARGCFLNAKRNKKP	PRAMEF26	26	H0Y7S4
MKGALERVICKRKNP	OR1E2	306	P47887
MSKGCFVFKPNSKKR	ORC3	6	Q9UBD5
RHGYCKGNPRKMVKT	RIOK1	231	Q9BRS2
RKRPKMYSKSIQTIC	RSBN1L	266	Q6PCB5
SAKGPCVERKAKLMT	SNN	66	O75324
CRGVKVMFNGKKLPV	TOP2B	271	Q02880
VSVCKGLMTKHPAKR	PRKCA	566	P17252
MVNVPKTRRTFCKKC	RPL36A	1	P83881
VAMPKRGKRLKFRAH	TMEM183BP	16	Q1AE95
TGFMCSQLPQFKKRR	SHOC1	1411	Q5VXU9
LQKECRPKFAKTSMA	ST3GAL5	116	Q9UNP4
LMGSSPVFNQRCKKR	SUPT7L	396	O94864
MAKNKLRGPKSRNVF	RBIS	1	Q8N0T1
RPFCFSVKGHVKMLR	CKLF	11	Q9UBR5
KRKMSCTICGHKFPR	ZBTB25	346	P24278
FGQMSGYRRKPTCKK	TRPC1	336	P48995
GYRRKPTCKKIMTVL	TRPC1	341	P48995
KLKMVPRKQREFSGS	XIRP2	2621	A4UGR9
CGKAFISLKRIRKHM	ZNF564	426	Q8TBZ8
RMTDKCFRKCIGKPG	TIMM13	41	Q9Y5L4
TSQRGTRKVPKCMKE	TXNDC16	756	Q9P2K2
FPIKNGRKVSCMKSA	ZNF804B	151	A4D1E1
DPRTCAKLMKLKGHT	WDR48	196	Q8TAF3
VAMPKRGKRLKFRAH	TMEM183A	16	Q8IXX5
GMKIDSKTPECRKFL	VTA1	46	Q9NP79
MKLCGEVKPKNKARR	KIF21A	1141	Q7Z4S6
SRCGKEGIKMPKTKR	ZNF292	2321	O60281
AMNFPRNKVCSKCKR	TEX13C	966	A0A0J9YWL9
MCIKRLQIKPRSFSG	TLR7	111	Q9NYK1
ICGKSFTSRPNMKRH	ZBTB47	636	Q9UFB7
TGQLFCLRKLMPAKT	ZNFX1	1161	Q9P2E3
CLRKLMPAKTFAGVR	ZNFX1	1166	Q9P2E3
CGKSFTSRPNMKRHR	ZNF652	446	Q9Y2D9
PQRFCKLRKIMNTKT	TLR2	746	O60603
MGLCKCPKRKVTNLF	ZFPL1	1	O95159
HLCKKKMRRKPESFG	TRPC4	676	Q9UBN4
VTPRMLCAGYRKGKK	TMPRSS6	741	Q8IU80
ACPGSEARHKMKKLT	ZNF789	86	Q5FWF6
ECGKTFTRRPNLMKH	ZNF34	311	Q8IZ26
CGKKFKSRGFLKRHM	ZFY	426	P08048
QKARGLEAKTCFRKM	ZMAT1	231	Q5H9K5
KARGLDPKTCFRKMR	ZMAT1	316	Q5H9K5
LIGCMFIKMSQPKKR	KCNJ3	176	P48549
TGASFIRCIKPNLKM	MYO6	661	Q9UM54
CPRATSAMKKAKLSG	MYT1L	1031	Q9UL68
RRVMPCYSKTQKLSK	NEUROD4	111	Q9HD90